tucaresol has been researched along with HIV Coinfection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandera, A; Biasin, M; Bray, D; Clerici, M; Ferrante, P; Franzetti, F; Galli, M; Gazzola, L; Gori, A; Marchetti, G; McDade, H; Moroni, M; Panebianco, R; Rhodes, J; Saresella, M; Thomas, N; Trabattoni, D | 1 |
| Bandera, A; Bulgheroni, E; Galli, M; Gori, A; Rusconi, S | 1 |
| Bray, D; Clerici, M; Cogliati, M; Colombo, F; Fossati, S; Piconi, S; Rhodes, J; Rizzardini, G | 1 |
2 trial(s) available for tucaresol and HIV Coinfection
| Article | Year |
|---|---|
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.
Topics: Adult; Antiretroviral Therapy, Highly Active; Benzaldehydes; Benzoates; Female; HIV Infections; HIV-1; Humans; Immunologic Factors; Lymphocyte Count; Male; Middle Aged; Pilot Projects; Pulse Therapy, Drug; RNA, Viral; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic | 2004 |
Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol.
Topics: Amino Acid Sequence; Benzaldehydes; Benzoates; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Immunologic Factors; Molecular Sequence Data; Peptide Fragments; Sequence Alignment; Time Factors; Treatment Outcome | 2005 |
1 other study(ies) available for tucaresol and HIV Coinfection
| Article | Year |
|---|---|
In vitro immunomodulatory properties of tucaresol in HIV infection.
Topics: Adjuvants, Immunologic; Antigens; Apoptosis; Benzaldehydes; Benzoates; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; HIV Infections; Humans; Interferon-gamma; Interleukin-2; Leukocytes, Mononuclear; Receptors, Interleukin-2; RNA, Messenger | 2000 |